ADRB2 and asthma: Regardless of evidence that steroids may not reverse the TGF-β1-induced remodeling effects [41] in asthma, our findings suggest that in asthma patients with high levels of TGF-β1, steroids may be an effective treatment to reverse β2AR hyporesponsiveness observed in these patients.